XP-524

N/A

Report date: 2026/01/15 17:08:56
NME

Base Information

Drug NameXP-524
Drug Alias NameXP-524
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone acetyltransferase p300 inhibitorsBromodomain and extra terminal domain protein inhibitors
TargetsBromodomain and extra terminal domain proteinHistone acetyltransferase p300
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Illinois At Chicago
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Illinois At Chicago
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A